Durham VA Medical Center

Running trials

• Not yet recruiting

  RISE for PTSD and Substance Use Disorder in Veterans

  NCT07903753· VA Office of Research and Development· Source

• Not yet recruiting

  Abstinence Reinforcement Therapy for Veterans Who Smoke Tobacco and Are Experiencing Homelessness

  NCT07714200· VA Office of Research and Development· Source

• Not yet recruiting

  Maximizing Quality of Life After Cancer Through Rehabilitation

  NCT07622407· VA Office of Research and Development· Source

• Not yet recruiting

  Self-Help Intervention for Post 9/11 Veterans With Depression or PTSD Symptoms

  NCT07202325· VA Office of Research and Development· Source

• Not yet recruiting

  Boosting Exercise Adherence in Knee Osteoarthritis

  NCT07219732· VA Office of Research and Development· Source

• Not yet recruiting

  Using Community Health Workers to Support Rural Care Partners of Seriously Ill Older Veterans

  NCT06963970· VA Office of Research and Development· Source

• Recruiting

  Varenicline for Smoking Reduction in Veterans Not Ready To Quit

  NCT06966362· Phase 4· VA Office of Research and Development· Source

• Recruiting

  Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)

  NCT07218354· Phase 3· VA Office of Research and Development· Source

• Recruiting

  Implementing Cognitive Behavioral Therapy for Insomnia (SWELL): Function QUERI 3.0

  NCT07216261· VA Office of Research and Development· Source

• Recruiting

  Implementing a Group Physical Therapy Program for Veterans (GroupPT): Function QUERI 3.0

  NCT07215572· VA Office of Research and Development· Source

• Recruiting

  Increasing Germline Genetic Testing for Patients With Cancer

  NCT07307664· Josh Peterson· Source

• Recruiting

  Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  NCT06931340· Phase 3· Alliance for Clinical Trials in Oncology· Source

• Recruiting

  A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

  NCT06520098· Phase 2· VA Office of Research and Development· Source

• Recruiting

  The Vanguard Study: Testing a New Way to Screen for Cancer

  NCT06995898· National Cancer Institute (NCI)· Source

• Recruiting

  Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  NCT06616584· Phase 2/3· SWOG Cancer Research Network· Source

• Recruiting

  Pharmacogenomic Informed Statin Prescribing

  NCT06568601· VA Office of Research and Development· Source

• Recruiting

  Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  NCT06498635· Phase 3· National Cancer Institute (NCI)· Source

• Recruiting

  Mobile Anger Reduction Intervention

  NCT06094933· VA Office of Research and Development· Source

• Recruiting

  A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

  NCT05563766· Phase 2· VA Office of Research and Development· Source

• Active, not recruiting

  Telehealth-based Symptom Management for Veterans Treated With Selinexor

  NCT06452446· Durham VA Medical Center· Source

• Recruiting

  Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

  NCT06096844· Phase 3· National Cancer Institute (NCI)· Source

• Recruiting

  Evaluating Treatments for Suicidal Veterans With PTSD

  NCT05974631· VA Office of Research and Development· Source

• Recruiting

  CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes

  NCT05931276· Phase 3· VA Office of Research and Development· Source

• Recruiting

  Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  NCT05946213· Phase 3· NRG Oncology· Source

• Recruiting

  Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

  NCT05486572· VA Office of Research and Development· Source

• Recruiting

  Neuroimaging Correlates and Feasibility of Transcranial Magnetic Stimulation (TMS) to Improve Smoking Cessation Outcomes in Veterans With Comorbid PTSD

  NCT05723588· Phase 2· VA Office of Research and Development· Source

• Recruiting

  The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial

  NCT05618353· Phase 4· VA Office of Research and Development· Source

• Recruiting

  Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  NCT05642572· Phase 2· SWOG Cancer Research Network· Source

• Recruiting

  Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

  NCT02915198· Phase 4· VA Office of Research and Development· Source

• Recruiting

  ERP to Improve Functioning in Veterans With OCD

  NCT05240924· VA Office of Research and Development· Source

• Recruiting

  Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  NCT05334069· Alliance for Clinical Trials in Oncology· Source

• Recruiting

  Family Involvement in Treatment for PTSD (FIT-PTSD): A Brief, Feasible Method for Enhancing Outcomes, Retention, and Engagement

  NCT05267665· VA Office of Research and Development· Source

• Active, not recruiting

  Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

  NCT05096663· Phase 2/3· SWOG Cancer Research Network· Source

• Recruiting

  Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

  NCT05080673· NRG Oncology· Source

• Active, not recruiting

  Screening for High Frequency Malignant Disease

  NCT05117840· Guardant Health, Inc.· Source

• Recruiting

  Hearing Impairment, Strategies and Outcomes in VA Emergency Departments

  NCT05028972· VA Office of Research and Development· Source

• Active, not recruiting

  Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

  NCT05050084· Phase 3· NRG Oncology· Source

• Active, not recruiting

  Telehealth to Improve Functional Status and Quality of Life in Veterans With PAD

  NCT05048979· VA Office of Research and Development· Source

• Recruiting

  High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

  NCT05011383· Phase 2· VA Office of Research and Development· Source

• Active, not recruiting

  Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

  NCT04787744· Phase 2/3· VA Office of Research and Development· Source

• Active, not recruiting

  Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

  NCT04625647· Phase 2· SWOG Cancer Research Network· Source

• Recruiting

  Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

  NCT04269902· Phase 3· National Cancer Institute (NCI)· Source

• Active, not recruiting

  Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

  NCT04513717· Phase 3· NRG Oncology· Source

• Active, not recruiting

  Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer

  NCT04214262· Phase 3· National Cancer Institute (NCI)· Source

• Recruiting

  Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

  NCT04239573· ECOG-ACRIN Cancer Research Group· Source

• Recruiting

  Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  NCT04267848· Phase 3· National Cancer Institute (NCI)· Source

• Active, not recruiting

  NCI COVID-19 in Cancer Patients, NCCAPS Study

  NCT04387656· National Cancer Institute (NCI)· Source

• Active, not recruiting

  S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer

  NCT04155034· Phase 3· SWOG Cancer Research Network· Source

• Active, not recruiting

  Targeted Treatment for RET Fusion-Positive Advanced Non-Small Cell Lung Cancer (A LUNG-MAP Treatment Trial)

  NCT04268550· Phase 2· SWOG Cancer Research Network· Source

• Active, not recruiting

  A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation

  NCT04104893· Phase 2· VA Office of Research and Development· Source

Showing 50 of 64.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer8 recruiting
• Prostate cancer7 recruiting
• Colorectal cancer4 recruiting
• Pancreatic cancer4 recruiting
• Gastric and oesophageal cancer3 recruiting
• Bladder cancer2 recruiting
• Chronic lymphocytic leukaemia2 recruiting
• Coronary artery disease2 recruiting
• Hearing loss2 recruiting
• Liver and biliary tract cancer2 recruiting
• Osteoarthritis2 recruiting
• Ovarian cancer2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• Acute myeloid leukaemia1 recruiting
• Childhood cancers1 recruiting
• Chronic kidney disease1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Familial hypercholesterolaemia1 recruiting
• Head and neck cancer1 recruiting
• Insomnia1 recruiting
• Kidney cancer1 recruiting
• Liver cirrhosis1 recruiting
• Melanoma1 recruiting
• Metastatic breast cancer1 recruiting
• Multiple myeloma1 recruiting
• Peripheral artery disease1 recruiting

Closed trials

• Completed

  Adapting Treatment Delivery to Improve Retention in Evidence-Based PTSD Treatment

  NCT06335589· VA Office of Research and Development· Source

• Completed

  Testing the Effectiveness of a Therapist-Assisted Self-Management Program for Veterans Who Finished PTSD Therapy

  NCT05797441· VA Office of Research and Development· Source

• Completed

  Implementing Group Physical Therapy (PT) for Veterans With Knee Osteoarthritis (Group PT): Function QUERI 2.0

  NCT05282927· VA Office of Research and Development· Source

• Completed

  TARDIS - Photo Elicitation and Intervention

  NCT06972251· VA Office of Research and Development· Source

• Completed

  Functional Outcomes of Cannabis Use (FOCUS) in Veterans With Posttraumatic Stress Disorder

  NCT04565028· VA Office of Research and Development· Source

• Completed

  Telehealth Treatment of Veterans With Alcohol Misuse at Risk for Cardiovascular Disease

  NCT04838457· VA Office of Research and Development· Source

• Completed

  realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

  NCT04981795· Incyte Corporation· Source

• Completed

  Exercise Training to Improve PTSD Symptoms and Health in Older Veterans

  NCT04199182· VA Office of Research and Development· Source

• Completed

  National Adaptive Trial for PTSD Related Insomnia

  NCT03668041· Phase 3· VA Office of Research and Development· Source

• Completed

  Psychotherapy for PTSD Among Veterans Also Receiving Drug or Alcohol Treatment

  NCT04581434· Center for Veterans Research and Education· Source

• Completed

  A Nurse-led Intervention to Extend the Veteran HIV Treatment Cascade for Cardiovascular Disease Prevention

  NCT04545489· VA Office of Research and Development· Source

• Completed

  Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial)

  NCT04173507· Phase 2· SWOG Cancer Research Network· Source

• Completed

  Veterans Achieving Weight Loss and Optimizing Resilience-Using Protein

  NCT03835416· VA Office of Research and Development· Source

• Completed

  CPT-SMART for Treatment of PTSD and Cigarette Smoking

  NCT03978442· Phase 4· VA Office of Research and Development· Source

• Completed

  Models of Primary Osteoporosis Screening in Male Veterans

  NCT04079868· VA Office of Research and Development· Source

• Completed

  A Novel Posttraumatic Stress Disorder Treatment for Veterans With Moral Injury

  NCT03764033· VA Office of Research and Development· Source

• Completed

  Neurosteroids for Treatment of PTSD in Veterans

  NCT03799562· Phase 2· VA Office of Research and Development· Source

• Completed

  Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)

  NCT03971474· Phase 2· SWOG Cancer Research Network· Source

• Completed

  Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

  NCT03845296· Phase 2· SWOG Cancer Research Network· Source

• Completed

  A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL

  NCT03740529· Phase 1/2· Loxo Oncology, Inc.· Source

• Completed

  A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

  NCT02975934· Phase 3· pharmaand GmbH· Source

• Completed

  Secondary Event Prevention Using Population Risk Management After PCI and for Anti-Rheumatic Medications

  NCT02694185· VA Office of Research and Development· Source

• Completed

  The National Myelodysplastic Syndromes (MDS) Study

  NCT02775383· National Heart, Lung, and Blood Institute (NHLBI)· Source

• Completed

  Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery

  NCT00324805· Phase 3· National Cancer Institute (NCI)· Source

• Completed

  Biomarkers for Oral Cancer

  NCT00341497· National Cancer Institute (NCI)· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Prostate cancer59 works · 15 trials